MaxCyte Inc.
Last updated September 27, 2026
Organization details
- Legal name
- MaxCyte Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- MXCT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001287098
Board of directors
-
Art Mandell · DirectorSince 2023
-
Douglas Doerfler · Director · President and CEOSince 2023
-
John Joseph Johnston · DirectorSince 2023
-
Maher Masoud · Director · President and CEOSince 2024
-
Patrick J. Balthrop · DirectorSince 2023
-
Rekha Hemrajani · DirectorSince 2023
-
Richard Douglas · DirectorSince 2023
-
Stanley C. Erck · DirectorSince 2023
-
William W. Brooke · DirectorSince 2023
-
Yasir B. Al-Wakeel · DirectorSince 2023
Chief executives
Douglas Doerfler
· President and CEO
Dates unknown
Maher Masoud
· President and CEO
Dates unknown
Board connections
2 of this board's directors also sit on 4 other boards.
- via Rekha Hemrajani
- via Richard Douglas
- via Rekha Hemrajani
- via Richard Douglas
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 20, 2024 | Ross Thomas M. Officer (EVP, GLOBAL SALES) | Option exercise | +33,333 | $1.64 | $54,666 |
| Jun 20, 2024 | Ross Thomas M. Officer (EVP, GLOBAL SALES) | Open-market sale | −33,333 | $4.09 | $136,332 |
| Jun 11, 2024 | Art Mandell Director | Grant or award | +21,367 | — | — |
| Jun 11, 2024 | Richard Douglas Director | Grant or award | +21,367 | — | — |
| Jun 11, 2024 | Rekha Hemrajani Director | Grant or award | +21,367 | — | — |
| Jun 11, 2024 | Stanley C. Erck Director | Grant or award | +21,367 | — | — |
| Jun 11, 2024 | Yasir B. Al-Wakeel Director | Grant or award | +21,367 | — | — |
| Jun 11, 2024 | John Joseph Johnston Director | Grant or award | +21,367 | — | — |
| Jun 11, 2024 | Patrick J. Balthrop Director | Grant or award | +21,367 | — | — |
| Jun 11, 2024 | William W. Brooke Director | Grant or award | +21,367 | — | — |
| Jun 10, 2024 | Maher Masoud Director, Officer (President and CEO) | Open-market purchase | +70,443 | $4.90 | $345,171 |
| Jun 7, 2024 | Maher Masoud Director, Officer (President and CEO) | Open-market purchase | +29,557 | $4.87 | $143,943 |
| Mar 26, 2024 | John Joseph Johnston Director | Option exercise | +5,000 | $2.14 | $10,700 |
| Mar 26, 2024 | John Joseph Johnston Director | Open-market sale | −5,000 | $4.41 | $22,050 |
| Mar 15, 2024 | Ross Thomas M. Officer (EVP, GLOBAL SALES & MARKETING) | Grant or award | +25,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.